tesamorelin vial: Frequently asked questions

Label the vial immediately with actual concentration (2mg/original volume) and recalculate injection volume before any administration. If you added 1mL bacteriostatic water expecting a 1mg vial but actually reconstituted 2mg, your solution is 2mg/mL. Double your intended concentration. Drawing 1mL for what you thought was a 1mg dose would deliver 2mg instead, doubling the administered amount and potentially causing joint discomfort, edema, or transient hyperglycemia. Recalculate: for a 1mg dose from a 2mg/mL solution, draw only 0.5mL.

Discard immediately. Cloudiness indicates bacterial contamination or peptide aggregation, both of which compromise safety and efficacy. Properly reconstituted tesamorelin with bacteriostatic water should remain clear and colorless throughout the 28-day refrigerated storage period. Cloudiness most commonly results from non-sterile reconstitution technique (unsterilized vial top, contaminated syringe needle, or using sterile water instead of bacteriostatic water), repeated punctures with the same needle, or temperature excursion that caused protein precipitation.

Use a medical-grade insulin cooler rated for 2–8°C maintenance without external power. FRIO wallets use evaporative cooling and maintain refrigeration temperature for 48 hours once activated, but require re-soaking every two days. For trips longer than 72 hours, portable electric coolers with USB charging or battery packs are more reliable. Unreconstituted lyophilized vials tolerate short-term ambient temperature (up to 25°C) for 24–48 hours, making it safer to travel with unreconstituted tesamorelin vial size units and reconstitute on-site if refrigeration access is uncertain.

Reconstitute the 2mg vial with 2mL bacteriostatic water to create a 1mg/mL solution, then draw 1.5mL per dose. Standard 1mL insulin syringes won't accommodate 1.5mL volume. Use a 3mL syringe with 0.1mL graduation marks instead. Alternatively, reconstitute with 1.33mL bacteriostatic water to yield 1.5mg/mL concentration, allowing a 1.5mg dose to be delivered in exactly 1mL injection volume. Though this non-standard dilution ratio increases measurement error risk during reconstitution.

Order multiple 2mg vials. Specifically, seven 2mg vials to cover 14mg total consumption. A single 5mg vial leaves 5mg unused at day 14, and that unused portion expires at day 28 whether touched or not. Seven 2mg vials let you reconstitute one vial every two days, keeping each preparation fresh and minimizing multi-dose contamination risk. The per-milligram cost is slightly higher, but you're paying for usable peptide rather than discarded volume.

Yes. A single 10mg vial reconstituted with 10mL bacteriostatic water yields 1mg/mL, and 0.3mg daily for 30 days consumes 9mg total. You're using 90% of the vial within the stability window, which is optimal efficiency. Reconstitute on day 1, draw 0.3mL (30 units on a U-100 syringe) daily, and discard the remaining 1mg on day 28. Alternative: ten 1mg vials if available, reconstituting three per week. But that multiplies sterile preparation events tenfold.

No. Freezing reconstituted peptide solutions causes ice crystal formation that disrupts protein structure irreversibly. The tesamorelin molecule aggregates during freeze-thaw cycles, rendering it biologically inactive even if it appears clear upon thawing. Once reconstituted, the 28-day refrigerated window is absolute. If a protocol delay exceeds the remaining stability period, discard the reconstituted vial and prepare a fresh one when ready to resume. This is why protocol timing must be locked before reconstitution. Not after.

Use a medical-grade cooler with reusable ice packs or a thermoelectric cooling case rated for 2–8°C. Standard ice chests with loose ice allow temperatures to drop below 0°C, which freezes the solution and causes ice crystal damage. Insulin travel cases designed for diabetic patients maintain 2–8°C for 12–48 hours depending on ambient temperature and are widely available. Monitor the internal temperature with a digital thermometer throughout transport. If the solution freezes or exceeds 8°C for more than 4 hours, discard it upon arrival rather than guessing at remaining potency.

Discard immediately without injecting. Cloudiness indicates protein aggregation; visible particles suggest either aggregation or microbial contamination. Neither is reversible. Aggregated Tesamorelin cannot bind to GHRH receptors and may trigger immune responses if injected. Particulate contamination introduces infection risk. Clear solution is necessary but not sufficient to confirm potency. Cloudy or particulate solution is definitive evidence of failure. Reconstitute a fresh vial using sterile technique and verify proper refrigeration throughout the storage period.

How long Tesamorelin vial lasts shortens proportionally to time spent above 8°C. A refrigerator that cycles between 4–10°C throughout the day subjects the peptide to cumulative thermal stress. If the average temperature stays below 8°C, expect 30–40% potency loss over a 28-day period compared to stable 4°C storage. Invest in a dedicated laboratory refrigerator with tight temperature control (±1°C variance), or use a secondary thermometer to verify your home refrigerator maintains 2–8°C consistently. Store the vial on a middle shelf toward the back, never in the door.

Contact the supplier immediately. Lyophilised Tesamorelin can tolerate brief ambient temperature exposure (24–48 hours at 20–25°C), but shipping in summer heat. Where package interiors reach 35–45°C in delivery trucks. Denatures the peptide irreversibly. Reputable suppliers like Real Peptides include temperature monitoring strips or data loggers with shipments; check the indicator to confirm the package stayed below 25°C. If the strip shows temperature excursions above 30°C, request a replacement vial. Most suppliers replace heat-damaged shipments at no cost when temperature abuse is documented.

Discard the vial. A reconstituted Tesamorelin solution left at room temperature (20–25°C) for 8–12 hours has crossed the oxidation threshold where methionine residues aggregate into insoluble complexes. Even if the solution appears clear, bioactivity has dropped below therapeutic levels. You cannot reverse peptide denaturation by re-refrigerating the vial. The financial loss from discarding one vial is significantly smaller than the research setback from using degraded peptide and attributing null results to the compound rather than handling error.